EMA starts translating PRAC drug labeling recommendations into all EU languages
This article was originally published in SRA
Executive Summary
The European Medicines Agency has started translating into all EU languages the recommendations its Pharmacovigilance Risk Assessment Committee issues on the changes that should be made to product information based on the assessment of safety signals1.